---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-116013"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:08:03.720296+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Collegium executes $25M accelerated share repurchase; initial delivery of 865K shares

## Summary
- Executed ASR with Jefferies LLC to repurchase $25M of Collegium common stock.
- Initial delivery of ~865,426 shares based on $23.11 closing price (Nov 8, 2023), ~80% of expected total.
- Final settlement expected in Q4 2023; shares outstanding ~33.1M as of Sep 30, 2023.
- Part of $100M share repurchase program authorized by Board in January 2023.

## SEC filing metadata
- accession: 0001104659-23-116013
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465923116013/0001104659-23-116013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465923116013/tm2330291d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-116013
- JSON: https://secwatch.observer/filing/0001104659-23-116013.json
- Plain text: https://secwatch.observer/filing/0001104659-23-116013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.